Normal coronary physiology assessed by intracoronary Doppler ultrasound

Herz

Volumn 30, Issue 1, 2005, Pages 8-16

  Webb, Carolyn M ^d   Collins, Peter ^d   Di Mario, Carlo ^a,b,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d NONE

Author keywords

Acetylcholine; Adenosine; Coronary flow reserve; Doppler; Intracoronary; Intravascular ultrasound; Papaverine

Indexed keywords

ACETYLCHOLINE; ADENOSINE; NITROPRUSSIDE SODIUM; PAPAVERINE; SUBSTANCE P;

ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC ACCURACY; DOPPLER FLOWMETRY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

BLOOD FLOW VELOCITY; CORONARY CIRCULATION; CORONARY VESSELS; ECHOCARDIOGRAPHY, DOPPLER; HUMANS; REFERENCE VALUES; ULTRASONOGRAPHY, INTERVENTIONAL; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 17144403254     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2647-z     Document Type: Article

References (44)

1. Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899-911.
2. Labovitz AJ, Williams GA. Doppler principles. Doppler echocardiography. The quantitative approach, 2 edn. Philadelphia: Lea & Febiger, 1988:1-8.
3. Tadaoka S, Kagiyama M, Hiramatsu O, et al. Accuracy of 20-MHz Doppler catheter coronary artery velocimetry for measurement of coronary blood flow velocity. Cathet Cardiovasc Diagn 1990;19:205-13.
4. Rang HP, Dale MM, Ritter JM. Pharmacology, 3edn. Churchill Livingstone: London 1995.
5. Wilson RF, Wyche K, Christensen BV, et al. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595-606.
6. Kern MJ, Deligonul U, Tatineni S, et al. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol 1991;18:718-29.
7. Wilson RF, White CW. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 1986;73:444-51.
8. Christensen CW, Rosen LB, Gal RA, et al. Coronary vasodilator reserve. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism. Circulation 1991;83:294-303.
9. Parham WA, Bouhasin A, Ciaramita JP, et al. Coronary hyperemic dose responses of intracoronary sodium nitroprusside. Circulation 2004;109:1236-43.
10. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
11. Lefroy DC, Crake T, Uren NG, et al. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993;88:43-54.
12. Ming Z, Parent R, Lavallee M. Nitric oxide-independent dilation of conductance coronary arteries to acetylcholine in conscious dogs. Circ Res 1997;1981:977-87.
13. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
14. Zeiher AM, Drexler H, Saurbier B, et al. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:652-62.
15. Weihe E, Reinecke M, Opherk D, et al. Peptidergic innervation (substance P) in the human heart. J Mol Cell Cardiol 1981;13:331-3.
16. Chester AH, O'Neil GS, Tadjkarimi S, et al. The role of nitric oxide in mediating endothelium dependent relaxations in the human epicardial coronary artery. Int J Cardiol 1990;29:305-9.
17. Tagawa T, Mohri M, Tagawa H, et al. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans. J Cardiovasc Pharmacol 1997;29:546-53.
18. Ouyyumi AA, Mulcahy D, Andrews NP, et al. Coronary vascular nitric oxide activity in hypertension and hypercholesterolaemia. Comparison of acetylcholine and substance P. Circulation 1997;95:104-10.
19. Crossman DC, Larkin SW, Fuller RW, et al. Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans. Circulation 1989;80:475-84.
20. Crossman DC, Larkin SW, Dashwood MR, et al. Responses of atherosclerotic human coronary arteries in vivo to the endothelium-dependent vasodilator substance P. Circulation 1991;84:2001-10.
21. Reis SE, Holubkov R, Lee JS, et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 1999;33:1469-75.
22. Hamaoka K, Onouchi Z, Ohmochi Y, et al. Coronary arterial flow-velocity dynamics in children with angiographically normal coronary arteries. Circulation 1995;92:2457-62.
23. Ofili EO, Kern MJ, St Vrain JA, et al. Differential characterization of blood flow, velocity, and vascular resistance between proximal and distal normal epicardial human coronary arteries: analysis by intracoronary Doppler spectral flow velocity. Am Heart J 1995;130:37-46.
24. Kern MJ, Bach RG, Mechem CJ, et al. Variations in normal coronary vasodilatory reserve stratified by artery, gender, heart transplantation and coronary artery disease. J Am Coll Cardiol 1996;28:1154-60.
25. Spann JAE. Structure and function of the coronary arterial tree. In: Spann JAE, ed. Coronary blood flow: mechanics, distribution and control. Boston: Kluwer Academic, 1991:37-67.
26. Klocke FJ. Measurements of coronary flow reserve: defining pathophysiology versus making decisions a bout patient care. Circulation 1987;76:1183-9.
27. Di Mario C, Kern M. Normal values: coronary flow. In: Erbel R, Roelandt JRTC, Ge J, et al. eds. Intravascular ultrasound. London: Dunitz, 1998:43-50.
28. Di Mario C, Gil R, Serruys PW. Long-term reproducibility of coronary flow velocity measurements in patients with coronary artery disease. Am J Cardiol 1995;75:1177-80.
29. McGinn AL, White CW, Wilson RF. Interstudy variability of coronary flow reserve. Influence of heart rate, arterial pressure, and ventricular preload. Circulation 1990;81:1319-30.
30. 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 1994;89:2150-60.
31. Kern MJ, Donohue TJ, Aguirre FV, et al. Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol 1995;25:178-87.
32. Webb CM, Ghatei M, McNeill JG, et al. 17β-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation 2000;102:1617-22.
33. Webb CM, McNeill JC, Hayward CS, et al. Effects of testosterone on coronary vasomotor regulation in men with coronary artery disease. Circulation 1999;100:1690-6.
34. Indolfi C, Piscione F, Villari B, et al. Role of alpha2-adrenoceptorsin normal and atherosclerotic human coronary circulation. Circulation 1992;86:1116-24.
35. Hongo M, Nakatsuka T, Watanabe N, et al. Effects of heart rate on phasic coronary blood flow pattern and flow reserve in patients with normal coronary arteries: a study with an intravascular Doppler catheter and spectral analysis. Am Heart J 1994;127:545-51.
36. Antony I, Lerebours C, Nitenberg A. Loss of flow-dependent coronary artery dilatation in patients with hypertension. Circulation 1995;91:1624-8.
37. Erbel R, Ge J, Bockisch A, et al. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. Eur Heart J 1996;17:880-9.
38. Duffy SJ, Castle SF, Harper RW, et al. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. Circulation 1999;100:1951-7.
39. Petropoulakis PN, Pavlides CS, Manginas AN, et al. Intracoronary flow velocity measurements in adjacent stenotic and normal coronary arteries during incremental intravenous dobutamine stress and intracoronary adenosine injection. Cathet Cardiovasc Intervent 1999;48:1-9.
40. Di Segni E, Higano ST, Rihal CS, et al. Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making. Cathet Cardiovasc Intervent 2001;54:34-40.
41. Stoel MG, Zijlstra F, Visser CA. Frame count reserve. Circulation 2003;107:3034-9.
42. Chamuleau SA, Siebes M, Meuwissen M, et al. Association between coronary lesion severity and distal microvascular resistance in patients with coronary artery disease. Am J Physiol 2003;285:H2194-200.
43. Lethen H, Tries P, Kersting S, et al. Validation of noninvasive assessment of coronary flow velocity reserve in the right coronary artery. A comparison of transthoracic echocardiographic results with intracoronary Doppler flow wire measurements. Eur Heart J 2003;24:1567-75.
44. Voudris V, Avramides D, Gatzov P, et al. The effect of rapid decreases of blood pressure by different mechanisms on coronary flow and flow reserve in normal coronary arteries. Am J Hypertens 2003;16:1000-5.